58 related articles for article (PubMed ID: 20561767)
1. Consistency between self-report and clinician-administered versions of the Yale-Brown Obsessive-Compulsive Scale.
Federici A; Summerfeldt LJ; Harrington JL; McCabe RE; Purdon CL; Rowa K; Antony MM
J Anxiety Disord; 2010 Oct; 24(7):729-33. PubMed ID: 20561767
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition.
Vogt GS; Avendaño-Ortega M; Schneider SC; Goodman WK; Storch EA
J Psychiatr Pract; 2022 Jul; 28(4):294-309. PubMed ID: 35797686
[TBL] [Abstract][Full Text] [Related]
3. The transdiagnostic structure of mental effort avoidance.
Patzelt EH; Kool W; Millner AJ; Gershman SJ
Sci Rep; 2019 Feb; 9(1):1689. PubMed ID: 30737422
[TBL] [Abstract][Full Text] [Related]
4. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.
Goodman WK; Price LH; Rasmussen SA; Mazure C; Fleischmann RL; Hill CL; Heninger GR; Charney DS
Arch Gen Psychiatry; 1989 Nov; 46(11):1006-11. PubMed ID: 2684084
[TBL] [Abstract][Full Text] [Related]
5. The Yale-Brown Obsessive Compulsive Scale: interview versus self-report.
Steketee G; Frost R; Bogart K
Behav Res Ther; 1996 Aug; 34(8):675-84. PubMed ID: 8870295
[TBL] [Abstract][Full Text] [Related]
6. Perceptual Decision Impairments Linked to Obsessive-Compulsive Symptoms are Substantially Driven by State-Based Effects.
Kaplan CM; Solway A
Comput Psychiatr; 2022; 6(1):79-95. PubMed ID: 38774779
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of One Videoconference-Based Exposure and Response Prevention Session at Home in Adjunction to Inpatient Treatment in Persons With Obsessive-Compulsive Disorder: Nonrandomized Study.
Voderholzer U; Meule A; Koch S; Pfeuffer S; Netter AL; Lehr D; Zisler EM
JMIR Ment Health; 2024 Mar; 11():e52790. PubMed ID: 38477970
[TBL] [Abstract][Full Text] [Related]
8. Feeling more confident to encounter negative emotions: The mediating role of distress tolerance on the relationship between self-efficacy and outcomes of exposure and response prevention for OCD.
Xu J; Falkenstein MJ; Kuckertz JM
J Affect Disord; 2024 May; 353():19-26. PubMed ID: 38423365
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Autoimmune Neuropsychiatric Disorder Linked to Streptococcal Infections.
Alqifari AN; Maxwell B
Case Rep Psychiatry; 2023; 2023():6667272. PubMed ID: 38116322
[TBL] [Abstract][Full Text] [Related]
10. Responsive deep brain stimulation guided by ventral striatal electrophysiology of obsession durably ameliorates compulsion.
Nho YH; Rolle CE; Topalovic U; Shivacharan RS; Cunningham TN; Hiller S; Batista D; Feng A; Espil FM; Kratter IH; Bhati MT; Kellogg M; Raslan AM; Williams NR; Garnett J; Pesaran B; Oathes DJ; Suthana N; Barbosa DAN; Halpern CH
Neuron; 2024 Jan; 112(1):73-83.e4. PubMed ID: 37865084
[TBL] [Abstract][Full Text] [Related]
11. Examination of Outcomes among Sexual Minorities in Treatment for Obsessive-Compulsive and Related Disorders.
Bezahler A; Kuckertz JM; Schreck M; Narine K; Dattolico D; Falkenstein MJ
J Obsessive Compuls Relat Disord; 2022 Apr; 33():. PubMed ID: 37220532
[TBL] [Abstract][Full Text] [Related]
12. "I Haven't Been Diagnosed, but I Should Be"-Insight Into Self-diagnoses of Common Mental Health Disorders: Cross-sectional Study.
Rutter LA; Howard J; Lakhan P; Valdez D; Bollen J; Lorenzo-Luaces L
JMIR Form Res; 2023 Jan; 7():e39206. PubMed ID: 36637885
[TBL] [Abstract][Full Text] [Related]
13. Does the network structure of obsessive-compulsive symptoms at treatment admission identify patients at risk for non-response?
Kuckertz JM; McNally RJ; Riemann BC; Van Borkulo C; Bellet BW; Krompinger JW; Van Kirk N; Falkenstein MJ
Behav Res Ther; 2022 Sep; 156():104151. PubMed ID: 35728274
[TBL] [Abstract][Full Text] [Related]
14. Associations of Autism Traits With Obsessive Compulsive Symptoms and Well-Being in Patients With Obsessive Compulsive Disorder: A Cross-Sectional Study.
Doi S; Kobayashi Y; Takebayashi Y; Mizokawa E; Nakagawa A; Mimura M; Horikoshi M
Front Psychol; 2021; 12():697717. PubMed ID: 34393929
[TBL] [Abstract][Full Text] [Related]
15. Fear conditioning and extinction in obsessive-compulsive disorder: A systematic review.
Cooper SE; Dunsmoor JE
Neurosci Biobehav Rev; 2021 Oct; 129():75-94. PubMed ID: 34314751
[TBL] [Abstract][Full Text] [Related]
16. Determining prognostic variables of treatment outcome in obsessive-compulsive disorder: effectiveness and its predictors in routine clinical care.
Herzog P; Osen B; Stierle C; Middendorf T; Voderholzer U; Koch S; Feldmann M; Rief W; Brakemeier EL
Eur Arch Psychiatry Clin Neurosci; 2022 Mar; 272(2):313-326. PubMed ID: 34218306
[TBL] [Abstract][Full Text] [Related]
17. Predictors of trajectories of obsessive-compulsive symptoms during the COVID-19 pandemic in the general population in Germany.
Jelinek L; Göritz AS; Miegel F; Moritz S; Kriston L
Transl Psychiatry; 2021 May; 11(1):323. PubMed ID: 34045444
[TBL] [Abstract][Full Text] [Related]
18. A multi-method examination of the link between obsessive-compulsive symptomatology and emotion-related impulsivity.
Hudiburgh SE; Reese HE; Carver CS; Çek D; Timpano KR
Br J Clin Psychol; 2021 Sep; 60(3):293-311. PubMed ID: 33836094
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Characteristics of Obsessive-Compulsive Disorder Among Urban Residents in Wuhan During the Stage of Regular Control of Coronavirus Disease-19 Epidemic.
Zheng Y; Xiao L; Xie Y; Wang H; Wang G
Front Psychiatry; 2020; 11():594167. PubMed ID: 33391055
[No Abstract] [Full Text] [Related]
20. Effects of the COVID-19 Pandemic on Obsessive-Compulsive Symptoms Among University Students: Prospective Cohort Survey Study.
Ji G; Wei W; Yue KC; Li H; Shi LJ; Ma JD; He CY; Zhou SS; Zhao Z; Lou T; Cheng J; Yang SC; Hu XZ
J Med Internet Res; 2020 Sep; 22(9):e21915. PubMed ID: 32931444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
